Application Note

Biopharmaceutical Characterization: Absolute Confidence First Time, Every Time, With MaXis Impact™

Source: Bruker Instruments Inc. (NMR)

Complete characterization of biopharmaceutical products and potential product impurities is essential for biotherapeutic product development, regulatory approval and production.

The maXis impact™ offers a quantum leap in data quality, delivering isotopic resolution of intact proteins up to 30-40kDa and sub-ppm mass accuracy. We present an industry first – a no compromise benchtop ESI-qTOF MS system providing full resolution (>40,000 FWHM) at full sensitivity achieving simultaneous characterization of product and impurities.

With software dedicated to the biopharmaceutical industry, Biopharma Compass™ automates acquisition and customized reporting of the superb quality data generated by the maXis impact ensuring absolute characterization confidence for your biopharmaceutical every time at the touch of a button.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online